Providence Medical Technology, Inc. today announced that it has closed a $6.8 million Series C round of financing. Stanmore Medical Investments led the round through its MedVest Fund One, and was joined by Aphelion Capital and RCT Ventures.
Our Mission is to establish Circumferential Cervical Fusion (CCF) as the standard of care for high-risk patients.
